Showing 221-240 of 499 for: Cochrane Systematic Reviews > Infectious disease 
- Herbal medicines for treating HIV infection and AIDS
Cochrane Systematic Reviews, 10-Nov-2008
HIV-infected people and AIDS patients often seek complementary therapies including herbal medicines due to reasons such as unsatisfactory effects, high cost, non-availability, or adverse effects of conventional medicines.
- High first dose quinine regimen for treating severe malaria
Cochrane Systematic Reviews, 11-May-2009
Quinine is used for treating severe malaria. There are arguments for giving an initial high dose. We examined the evidence for and against this policy.
- Home versus hospital intravenous antibiotic therapy for cystic fibrosis
Cochrane Systematic Reviews, 8-Mar-2012
Recurrent endobronchial infection in cystic fibrosis requires treatment with intravenous antibiotics for several weeks usually in hospital, affecting health costs and quality of life for patients and their families.
- Home-based care for reducing morbidity and mortality in people infected with HIV/AIDS
Cochrane Systematic Reviews, 11-Nov-2009
Home-based care (HBC), to promote quality-of-life and limit hospital care, is used in many countries, especially where public health services are overburdened.
- Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing
Cochrane Systematic Reviews, 15-Jun-2010
The low uptake of HIV voluntary counselling and testing (VCT) has hindered global attempts to prevent new HIV infections and has limited scale-up of HIV care and treatment. Globally, only 10% of HIV-infected individuals are aware of their HIV status. One
- Human recombinant activated protein C for severe sepsis
Cochrane Systematic Reviews, 17-Apr-2012
Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been used to reduce the high rate of death by severe sepsis or septic shock. This is an update of a Cochrane review (originally published in 2007 and update
- Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients
Cochrane Systematic Reviews, 12-Aug-2008
Hypertonic solutions are considered to have a greater ability to expand blood volume and thus elevate blood pressure and can be administered as a small volume infusion over a short time period. On the other hand, the use of hypertonic solutions for volume
- Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults
Cochrane Systematic Reviews, 7-Feb-2010
Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. Subsequent trials in asymptomatic or early symptomatic HIV infection indicated short-term delays in disease progression with AZT, but not improved survival.
- Immunoglobulin for preventing respiratory syncytial virus infection
Cochrane Systematic Reviews, 16-Jun-2008
Respiratory Syncytial virus, the most important cause of lower respiratory tract infections in infants and young children in industrialized countries, is associated with increased morbidity in premature infants with or without bronchopulmonary dysplasia a
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Cochrane Systematic Reviews, 17-Mar-2010
Cytomegalovirus (CMV) is the most common virus causing disease and death in solid organ transplant recipients during the first six months post-transplant. Previous systematic reviews have demonstrated the efficacy of antiviral medications used prophylacti
- Immunostimulants for preventing respiratory tract infection in children
Cochrane Systematic Reviews, 20-Apr-2011
Acute respiratory tract infections (ARTIs) are a major cause of childhood morbidity and mortality. Immunostimulants (IS) may reduce the incidence of ARTIs.
- Immunosuppressive agents for myasthenia gravis
Cochrane Systematic Reviews, 2-Nov-2008
The benefits of different immunosuppressants for myasthenia gravis (MG) are unclear.
- Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
Cochrane Systematic Reviews, 27-Jul-2008
Immunosuppressive and cytotoxic agents have been used as both an alternative to oral corticosteroids, and as a means of maintaining a low dose of steroids in the treatment of pulmonary sarcoidosis.
- Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome
Cochrane Systematic Reviews, 12-May-2009
Idiopathic membranous nephropathy (IMN) is the most common form of nephrotic syndrome in adults. The disease shows a benign or indolent course in the majority of patients, with a rate of spontaneous complete or partial remission of nephrotic syndrome as h
- Indoor residual spraying for preventing malaria
Cochrane Systematic Reviews, 13-Apr-2010
Primary malaria prevention on a large scale depends on two vector control interventions: indoor residual spraying (IRS) and insecticide-treated mosquito nets (ITNs). Historically, IRS has reduced malaria transmission in many settings in the world, but the
- Infection control strategies for preventing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people
Cochrane Systematic Reviews, 28-Oct-2011
Nursing homes for older people provide an environment likely to promote the acquisition and spread of meticillin-resistant Staphylococcus aureus (MRSA), putting residents at increased risk of colonisation and infection. It is recognised that infection pre
- Influenza vaccination for healthcare workers who work with the elderly
Cochrane Systematic Reviews, 4-Aug-2010
Healthcare workers’ (HCWs) influenza rates are unknown, but may be similar to the general public and they may transmit influenza to patients.
- Influenza vaccination in children being treated with chemotherapy for cancer
Cochrane Systematic Reviews, 6-Dec-2010
Influenza infection is a potential cause of severe morbidity in children with cancer, therefore vaccination against influenza is recommended. However, there are conflicting data concerning the immune response to influenza vaccination in children with canc
- Influenza vaccine for children and adults with bronchiectasis
Cochrane Systematic Reviews, 20-Jul-2010
Bronchiectasis is a major cause of respiratory morbidity especially in developing countries. In affluent countries, bronchiectasis is increasingly recognised in certain subsections of communities (e.g. Aboriginal communities) as well as a coexistent disea
- Influenza vaccine for patients with chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 24-Jun-2010
Influenza vaccinations are currently recommended in the care of people with COPD, but these recommendations are based largely on evidence from observational studies with very few randomised controlled trials (RCTs) reported. Influenza infection causes exc
